{"disease":{"id":"immune-system","name":"immune system"},"drugs":{"marketed":[{"drug_id":"curcumin","indication_name":"low or imbalance immune system","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Immune Support","generic_name":"CURCUMIN","company_name":"ProBLEN","drug_phase":"marketed","molecular_target":"","drug_class":"Vitamin C [EPC]","quality_score":13,"revenue":null,"mechanism":""},{"drug_id":"15-valent-pneumococcal-conjugate-vaccine-pcv15","indication_name":"Prevention of invasive pneumococcal disease caused by 15 serotypes of Streptococcus pneumoniae in adults 18 years of age and older with other conditions that compromise the immune system.","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"15-valent pneumococcal conjugate vaccine (PCV15)","generic_name":"15-valent-pneumococcal-conjugate-vaccine-pcv15","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"Streptococcus pneumoniae","drug_class":"vaccine","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"pfizer-biontech-covid-19-mrna-vaccine","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Pfizer-BioNTech COVID-19 mRNA vaccine","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2","drug_class":"vaccine","quality_score":38,"revenue":null,"mechanism":"mRNA vaccine that uses a piece of genetic material to instruct cells to produce a protein that triggers an immune response"},{"drug_id":"bnt162b2-omi-xbb-1-5","indication_name":"Prevention of COVID-19 in individuals 12 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b2 (Omi XBB.1.5)","generic_name":"bnt162b2-omi-xbb-1-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"mRNA vaccine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"bnt162b2-omi-xbb-1-5","indication_name":"Prevention of COVID-19 in individuals 6 months of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b2 (Omi XBB.1.5)","generic_name":"bnt162b2-omi-xbb-1-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"mRNA vaccine","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"bnt162b2-omi-xbb-1-5","indication_name":"Prevention of COVID-19 in individuals 5 years of age and older with weakened immune systems","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"BNT162b2 (Omi XBB.1.5)","generic_name":"bnt162b2-omi-xbb-1-5","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"SARS-CoV-2 spike protein","drug_class":"mRNA vaccine","quality_score":40,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":82,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05013944","title":"AnovaOS Network Powered Patient Registry","phase":"","overall_status":"RECRUITING","enrollment_count":100000,"lead_sponsor_name":"Anova Enterprises, Inc","has_results":false},{"nct_id":"NCT03503747","title":"Investigating Genetic Risk for Type 1 Diabetes","phase":"","overall_status":"COMPLETED","enrollment_count":15640,"lead_sponsor_name":"University of Oxford","has_results":false},{"nct_id":"NCT05154370","title":"China National Registry of Neuro-Inflammatory Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":10000,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT03922087","title":"No-worry Baby Project","phase":"","overall_status":"COMPLETED","enrollment_count":5216,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT05414890","title":"Sensitivity and Specificity of TSA-CBA for Autoantibodies Against Neural Antigen Determination","phase":"","overall_status":"UNKNOWN","enrollment_count":2500,"lead_sponsor_name":"Beijing Tiantan Hospital","has_results":false},{"nct_id":"NCT03925272","title":"Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":2200,"lead_sponsor_name":"Institut Pasteur","has_results":false},{"nct_id":"NCT04749875","title":"Study of Leukocyte Populations in Patients With Chronic Inflammatory","phase":"","overall_status":"UNKNOWN","enrollment_count":1500,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT03627767","title":"Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1235,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05174624","title":"The Healthy Human Global Project - Hong Kong (HHGP-Hong Kong)","phase":"","overall_status":"COMPLETED","enrollment_count":1026,"lead_sponsor_name":"Centre for Immunology & Infection","has_results":false},{"nct_id":"NCT03276923","title":"Maternal Autoimmune Disease Research Alliance (MADRA) Registry","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Duke University","has_results":false},{"nct_id":"NCT05002023","title":"PRINCE Study - Cohort Study of Healthy Pregnant Women Followed by the Assessment of Children´s Health and Immunity","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT03963700","title":"Tumor Characteristics in Patients With Paraneoplastic Neurological Syndromes (PNS)","phase":"","overall_status":"UNKNOWN","enrollment_count":980,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT03720470","title":"Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":838,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT00001406","title":"Activation and Function of Eosinophils in Conditions With Blood or Tissue Eosinophilia","phase":"","overall_status":"RECRUITING","enrollment_count":800,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04977739","title":"Research on the Application and Mechanism of New Biological Probes in Biomedicine","phase":"","overall_status":"COMPLETED","enrollment_count":737,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT03207854","title":"Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers","phase":"","overall_status":"RECRUITING","enrollment_count":625,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT00006150","title":"Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)","phase":"","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06339957","title":"Rheumatology Diet Study","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"University of Central Florida","has_results":false},{"nct_id":"NCT01132859","title":"VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older","phase":"","overall_status":"RECRUITING","enrollment_count":500,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT05516758","title":"A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":491,"lead_sponsor_name":"Eli Lilly and Company","has_results":true},{"nct_id":"NCT05650502","title":"Impact of Seasonal Malaria Chemoprevention on Immunity Against Malaria Among Children in Northern Benin","phase":"","overall_status":"COMPLETED","enrollment_count":440,"lead_sponsor_name":"Université de Parakou","has_results":false},{"nct_id":"NCT04802044","title":"COVID-19, Aging, and Cardiometabolic Risk Factors Study","phase":"","overall_status":"UNKNOWN","enrollment_count":440,"lead_sponsor_name":"Indonesia University","has_results":false},{"nct_id":"NCT02579967","title":"Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":354,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT06169150","title":"Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity","phase":"","overall_status":"RECRUITING","enrollment_count":350,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT06503952","title":"Impact of Uterine Immune Profiling and Personalized Treatments in Patients Receiving a Single Blastocyst: a Matched Controlled Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":340,"lead_sponsor_name":"Matricelab Innove","has_results":false},{"nct_id":"NCT03922724","title":"Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":330,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT07298733","title":"The Value of Interleukin-1β and Interleukin-33 Genetic Expression in the Pathogenesis and Differentiation of Primary ITP and SLE-Related Thrombocytopenia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT03816345","title":"Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false},{"nct_id":"NCT05354765","title":"Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA","phase":"NA","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Institut Curie","has_results":false},{"nct_id":"NCT05168215","title":"Effectiveness of Bosentan Therapy in Patients With Systemic scleRosis and Progressive Digital ulcEr Disease.","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"Elpen Pharmaceutical Co. Inc.","has_results":false},{"nct_id":"NCT03054428","title":"Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":251,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":true},{"nct_id":"NCT03357939","title":"Phase I Study of HLX3 vs Adalimumab in Chinese Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"Shanghai Henlius Biotech","has_results":false},{"nct_id":"NCT03557749","title":"Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies","phase":"","overall_status":"TERMINATED","enrollment_count":210,"lead_sponsor_name":"Masonic Cancer Center, University of Minnesota","has_results":false},{"nct_id":"NCT04103099","title":"Impact of HLNatural Immune Supplement on Colds","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Hawthorne Effect Inc.","has_results":false},{"nct_id":"NCT06353087","title":"Abrocitinib Taiwan Treatment Pattern and Real World Study in ATopiC Dermatitis (ATTRACT Registry)","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT05334888","title":"Sex-differential Host-microbiome CVD Risk - A Longitudinal Cohort Approach","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT04275440","title":"Effects of Caloric Restriction and Exercise on Body Weight, Immune Function, and Intestinal Flora","phase":"NA","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"Sun Yat-sen University","has_results":false},{"nct_id":"NCT04830046","title":"Covid-19 Vaccine Responsiveness in MM and Waldenstrom","phase":"","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT06073613","title":"Periodontal Status in Patients With Chronic Skin Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":146,"lead_sponsor_name":"University of Medicine and Pharmacy at Ho Chi Minh City","has_results":false},{"nct_id":"NCT06263686","title":"Evaluation of the Effects of Routine Intake of Fresh vs- Pasteurized Yoghurt on the Immune System in Healthy Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"University of Valladolid","has_results":false},{"nct_id":"NCT04751396","title":"Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors","phase":"","overall_status":"RECRUITING","enrollment_count":125,"lead_sponsor_name":"M.D. Anderson Cancer Center","has_results":false},{"nct_id":"NCT05432362","title":"ESAN II - Energy Sensing in Depression","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Medical University of Graz","has_results":false},{"nct_id":"NCT04186871","title":"Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":119,"lead_sponsor_name":"Bristol-Myers Squibb","has_results":true},{"nct_id":"NCT03688074","title":"Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT03941184","title":"Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity","phase":"","overall_status":"COMPLETED","enrollment_count":114,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05026242","title":"Effects of Almond Consumption on Innate and Adaptive Immune System","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":110,"lead_sponsor_name":"Institut Investigacio Sanitaria Pere Virgili","has_results":false},{"nct_id":"NCT03345004","title":"Diamyd Administered Into Lymph Nodes in Combination With Vitamin D in Type 1 Diabetes","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"Diamyd Medical AB","has_results":true},{"nct_id":"NCT04757987","title":"An Observational Study of Distress, Immune Function, and Pain in HIV.","phase":"","overall_status":"COMPLETED","enrollment_count":107,"lead_sponsor_name":"University of Cape Town","has_results":false},{"nct_id":"NCT07348432","title":"The diabEAT Study: Insulin dElivery Technologies And eaTing Behaviours in People With Type 1 Diabetes","phase":"","overall_status":"RECRUITING","enrollment_count":106,"lead_sponsor_name":"McGill University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}